Press release
Competitive Landscape: Key Market Leaders and New Entrants in the Hepatitis B Virus (HBV) Market
Hepatitis B Virus (HBV) Market
Hepatitis B Virus Market Size and Growth Forecast
The HBV market is projected to reach a value of $11.77 billion by 2030, growing at a compound annual growth rate (CAGR) of 10.2%. This expansion is fueled by increasing research and development activities in HBV therapeutics, the broadening reach of government-led vaccination initiatives, the rise of precision medicine, greater healthcare spending, and improvements in screening and diagnostic services. Key trends during this period include stronger adoption of antiviral medications, enhanced hepatitis B vaccination efforts, development of combination treatment therapies, special attention to managing HBV in pediatric and geriatric populations, and growth in diagnostic infrastructure.
Download a free sample of the hepatitis b virus (hbv) market report:
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Key Drivers Behind Hepatitis B Virus Market Expansion
The surge in government vaccination programs is a major force propelling the hepatitis B virus market forward. These initiatives aim to curb infection rates by increasing vaccine accessibility and coverage, particularly in high-risk regions.
Additionally, ongoing research and development into newer therapeutic options and more effective antiviral drugs are helping to improve patient outcomes, further stimulating market growth. Advancements in precision medicine also allow for more targeted and personalized treatment strategies, which are gaining traction in clinical settings.
The rising healthcare expenditure worldwide, coupled with expanded screening and diagnostic services, ensures earlier detection and better management of HBV, supporting sustained market development.
Leading Companies Driving Innovation in the Hepatitis B Virus Market
Some of the prominent players in the HBV market include Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bristol-Myers Squibb Company, Sanofi SA, GlaxoSmithKline PLC, and Gilead Sciences Inc. Others making significant contributions include Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Apotex Corp., Lupin Pharmaceuticals Inc., Cadila Healthcare Ltd., Dynavax Technologies Corporation, Accord Healthcare Inc., Par Pharmaceutical Inc., Arbutus Biopharma Corporation, and Antios Therapeutics Inc.
In a notable move, Brii Biosciences Ltd., a biotechnology company based in China, secured licensing rights from VBI Vaccines Inc. in July 2023 for an experimental hepatitis B immunotherapy and an approved vaccine. This acquisition strengthens Brii Biosciences' portfolio in HBV prevention and treatment. VBI Vaccines, located in the US, specializes in developing vaccines aimed at preventing hepatitis B infection.
View the full hepatitis b virus (hbv) market report:
https://www.thebusinessresearchcompany.com/report/hepatitis-b-virus-hbv-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Emerging Trends Highlighting HBV Market Innovation
Key market players are actively pursuing the development of innovative therapies through clinical trials, while also accelerating regulatory approvals to improve treatment effectiveness and stay ahead competitively.
For instance, in August 2025, Aligos Therapeutics from the US initiated patient dosing in its Phase II B-SUPREME trial testing ALG-000184, an oral capsid assembly modulator designed for chronic hepatitis B. This randomized, double-blind study involves approximately 200 treatment-naïve adults, comparing the new drug against tenofovir disoproxil fumarate over 48 weeks. The primary aim is to reduce HBV DNA levels below detectable limits in both HBeAg-positive and HBeAg-negative participants, with additional assessments of safety, pharmacokinetics, and antigen changes. Earlier Phase I results demonstrated strong antiviral effects and favorable tolerability, supporting the drug's potential. Interim trial data is expected by 2026, with final topline results anticipated in 2027.
Segmentation Overview of the Hepatitis B Virus Market
This report segments the HBV market based on several factors:
1) By Type: Acute and Chronic hepatitis B
2) By Treatment: Immune modulator drugs, antiviral drugs, vaccine, and surgery
3) By Age Group: Pediatrics, adults, and seniors
4) By End User: Medical providers, patients, and healthcare payers
Further classification includes subcategories such as:
- Acute HBV: asymptomatic acute HBV, symptomatic acute HBV, and severe acute HBV
- Chronic HBV: chronic hepatitis B with HBeAg positive, HBeAg negative, compensated liver disease, decompensated liver disease, and hepatocellular carcinoma (HCC)
These detailed segments provide a comprehensive understanding of the different facets and patient populations affected by hepatitis B.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Competitive Landscape: Key Market Leaders and New Entrants in the Hepatitis B Virus (HBV) Market here
News-ID: 4471885 • Views: …
More Releases from The Business Research Company
Kidney Cancer Drugs Market Overview: Major Segments, Strategic Developments, and …
The kidney cancer drugs market is on track for significant growth in the coming years, driven by cutting-edge innovations and evolving treatment approaches. As advances in medicine and technology continue to shape the industry, this sector is expected to experience steady expansion through 2030. Here, we explore the market size projections, key players, emerging trends, and segmentation details that define the current and future landscape of kidney cancer therapies.
Projected Growth…
Market Growth Patterns, Segment Analysis, and Competitive Approaches Influencing …
The Janus kinase (JAK) inhibitors market is set for remarkable expansion over the coming years, driven by scientific breakthroughs and growing therapeutic applications. As innovative drugs and delivery technologies emerge, this industry is becoming increasingly vital in treating a variety of health conditions. Let's explore the market's projected value, key players, evolving trends, and the main segments shaping its future.
Projected Market Value and Growth of the Janus Kinase (JAK) Inhibitors…
Overview of Segmentation, Market Dynamics, and Competitive Landscape in the Isot …
The isotretinoin drugs market is positioned for steady expansion as we approach 2030, driven by various healthcare trends and growing demand for effective acne treatments. This overview explores the anticipated market size, the main players shaping the industry, evolving trends, and the key segments that define this pharmaceutical sector.
Projected Market Size and Growth of the Isotretinoin Drugs Market
The isotretinoin drugs market is forecasted to reach a valuation of $1.7 billion…
Interferons Market Overview, Key Trends, and Major Player Analysis
The interferons market is positioned for impressive growth over the coming years, driven by advancements in medical therapies and expanding access to treatments. As healthcare continues to evolve, interferons are becoming increasingly vital in managing a range of diseases, signaling promising opportunities for industry players and patients alike. Let's explore the market size projections, key players, emerging trends, and detailed segmentation shaping the interferons industry.
Projected Growth and Market Size of…
More Releases for HBV
Emerging Hepatitis B Virus (HBV) Market Trends: Rising Emphasis On Highly Sensit …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts
Hepatitis B Virus (HBV) Market Size Growth Forecast: What to Expect by 2025?
The market for the hepatitis B virus (HBV) has expanded significantly in the last few years. The market is set to grow from its size of $6.71 billion in 2024 to an anticipated $7.37 billion in…
HIV/HBV/HCV Test Kits Market - Break the chain: Detect and prevent HIV, HBV, and …
Newark, New Castle, USA: The "HIV/HBV/HCV Test Kits Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
HIV/HBV/HCV Test Kits Market: https://www.growthplusreports.com/report/hivhbvhcv-test-kits-market/8774
This latest report researches the industry structure,…
Hepatitis B Virus [HBV] Treatment market ready to register a 5.30% CAGR
Actual Numbers & In-Depth Analysis, Business opportunities, Market Size Estimation Available in Full Report.
Executive Summary -:
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hepatitis B Treatment Market by Type (Therapeutics and Vaccines), By End-User (Male and Female) for the regions (North America, Europe, Asia—Pacific and ROW) and By Country (U.S., Canada,…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
Rising Prevalence of HBV and HCV Drives the Global Hepatitis Diagnostics Market
Hepatitis is a medical condition characterized by inflammation of the liver which often leads to other complications such as jaundice, anorexia, liver failure and cirrhosis. Hepatitis is generally of two types- acute when it lasts for less than six months and chronic when it lasts for longer period. It can be caused by a group of viruses called as hepatitis viruses which include groups A, B, C, D, and E.…
Global Hepatitis B Virus (HBV) Market: 10-Year Demand Forecast (2016-2025)
Hepatitis B is a virus that infects the liver. For most adults who suffer from it for a short time, it is called acute hepatitis B. Sometimes the virus causes a long-term infection which is called chronic hepatitis B. Over time, it can damage the liver. Babies and young children infected with the virus are more likely to get chronic hepatitis B. Abdominal pain, fever, dark urine and joint pain…
